Related Experiment Video
Updated: Jan 15, 2026

Author Spotlight: Creating Human Vascularized Micro-Tumors as Models for Translational Cancer Research
Published on: September 15, 2023
A Hybrid Technology-Enabled Financial Navigation Model to Combat Financial Toxicity in Cancer Care
Dinesh Pal Mudaranthakam1,2,3, Allison Makovec1, Rachel Forcino3
1The Department of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, KS, USA.
Abstract:
Financial toxicity is increasingly recognized as a critical barrier to high-quality cancer care, treatment adherence, and positive survivorship outcomes. Despite the availability of financial and social support resources, patients often face challenges in accessing and navigating them effectively. To address this gap, the University of Kansas Cancer Center developed the Oncology Navigation Empowerment for Treatment (ONCO-NET) platform-an innovative hybrid intervention that integrates an AI-driven resource-matching system with human-centered financial navigation support. Through a structured intake process that includes demographic information, the Functional Assessment of Chronic Illness Therapy Comprehensive Score for Financial Toxicity (FACIT-COST), and social determinants of health data, ONCO-NET identifies and prioritizes the most relevant local resources for each patient. The platform provides real-time, personalized recommendations while offering access to trained financial navigators for additional support. By combining digital technology with human expertise, ONCO-NET enhances accessibility, scalability, and equity in financial navigation. This approach has the potential to improve treatment adherence, reduce disparities, and serve as a scalable model for addressing financial burdens in cancer care and other chronic disease contexts.
More Related Videos
10:24Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
Published on: September 19, 2019
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...